PE-22-28 (Mini-Spadin)
Also known as: Mini-Spadin
Primary recreational use: Cognitive and mood enhancement
What is PE-22-28 (Mini-Spadin)?
PE-22-28, or Mini-Spadin, is a heptapeptide derived from the parent peptide Spadin, developed for its potent antagonism of the TREK-1 channel. Known for rapid antidepressant effects, it enhances neurogenesis and synaptogenesis, potentially benefiting mood disorders. The peptide remains unapproved by the FDA and is primarily available as a research compound.
Primary Benefits
Rapid antidepressant effects. Enhances neurogenesis. Improves synaptogenesis.
How It Works
PE-22-28 acts by selectively blocking the TREK-1 potassium channels, which increase neuronal excitability and enhance serotonin neurotransmission. This inhibition leads to the activation of CREB and BDNF, promoting neurogenesis in the hippocampus.
Safety Tips
Precautions reported in community discussions and literature. This is not a complete list.
- 1.DON'T exceed research protocol dosing ranges.
- 2.DON'T combine with MAOIs or high-dose SSRIs due to serotonin syndrome risk.
- 3.DON'T use if you are pregnant or breastfeeding.
- 4.AVOID using poor quality peptides lacking third-party testing.
- 5.NEVER shake the solution violently during reconstitution.
Use Contexts
Different purposes have different protocols, dosing, and considerations
Depression research
moderate evidencePE-22-28 is studied for its rapid antidepressant effects and potential neurogenesis enhancement.
Evidence: Preclinical studies show significant antidepressant effects with enhanced neurogenesis.
The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.
Timing: Morning dosing
Notes: Comparable to preclinical dosing adjusted for human equivalency.
Community-Reported Protocols
Not recommendations: The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.
| Reported Goal | Reported Dose | Reported Frequency | Reported Route |
|---|---|---|---|
| Preclinical Antidepressant Study | 3-4 mcg/kg | Once daily | Intraperitoneal (animal model) |
Pharmacokinetics
Reported Side Effects
This is not a complete list. Other side effects may occur.
Common
Serious / Rare
- Potential serotonin syndrome.
Injection-Specific Warnings
- Use sterile technique to avoid infections.
Storage
Harm Reduction Information
Quality Concerns
- Quality may vary by supplier; ensure third-party testing.
- Poor storage conditions can degrade peptide.
Safety Tips
- Start with the lowest effective dose.
- Use sterilized water for reconstitution.
- Avoid combining with contraindicated drugs like MAOIs.
- Use sterile technique for injections.
- Rotate injection sites to prevent tissue damage.
Warning Signs to Stop
- Unexpected allergic reactions.
- Signs of serotonin syndrome like confusion or agitation.
Seek Medical Help Immediately If
- If serotonin syndrome symptoms occur.
Frequently Asked Questions
Common questions about PE-22-28 (Mini-Spadin)
How long until I see effects?
PE-22-28 shows measurable antidepressant effects within 4 days according to preclinical models.
What time of day should I take it?
PE-22-28 is usually administered in the morning, with a duration of action around 23 hours.
How can I minimize side effects?
To minimize side effects, use PE-22-28 at the lowest effective dose and avoid combining it with contraindicated drugs like MAOIs.
Does tolerance develop?
Information on tolerance development with PE-22-28 is limited, so users should adhere to cycling protocols.
How should I store it?
Store PE-22-28 in the refrigerator at 2-8°C, and use reconstituted solutions within 4-6 weeks.
Reported Combinations
Compounds reported to be used alongside PE-22-28 (Mini-Spadin) in community discussions
Semax
Potential synergistic effects on cognitive and mood enhancements.
Cerebrolysin
May enhance neurotrophic benefits.
BPC-157
Compatible and potentially synergistic for neuroprotection.
Reported Interactions
Interactions reported in literature and community discussions.
Increased risk of serotonin syndrome when combined.
Potentially dangerous interaction increasing serotonin syndrome risk.
No known interaction; generally considered safe.
Reconstitution Calculator
100 units = 1 mL
Safety Tips
- Always consult a licensed medical professional for dosing and reconstitution instructions.
- Always double check your units. Mixing up mg and mcg can be very dangerous.
- Make sure to select your syringe type. U-100 and U-50 syringes have different units.
- Ensure you're not adding more BAC than your vial can hold. Most vials have maximum capacities listed.
This calculator is for informational and educational purposes only. It does not provide medical advice, dosing recommendations, or safety determinations. Reference ranges shown are compiled from publicly available sources and are not a substitute for guidance from a licensed healthcare professional.
Legal Status by Region
Regulatory status varies by country
USA
Research chemical only
UK
Research purposes only
EU
Research purposes only
Australia
Research purposes only
Canada
Research purposes only
Explore More Research
Browse our database of peptide research information compiled from published literature and community sources.
Citations
Last updated: October 15, 2023